A carregar...

A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer

About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients for adjuva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Jacob, Havjin, Stanisavljevic, Luka, Storli, Kristian Eeg, Hestetun, Kjersti E., Dahl, Olav, Myklebust, Mette P.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906690/
https://ncbi.nlm.nih.gov/pubmed/29670141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-24519-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!